Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Heliyon ; 8(9): e10422, 2022 Sep.
Article in English | MEDLINE | ID: covidwho-2007718

ABSTRACT

At this time, the literature reports only one case of superinfection with Panton-Valentine leukocidin (PVL)-producing Staphylococcus aureus in a patient with severe acute respiratory distress syndrome secondary to coronavirus 2 (SARS-CoV-2) pneumonia. Here we report the first two cases of PVL-producing S. aureus healthcare-associated pneumonia in patients hospitalized for SARS-CoV-2 pneumonia in the Indian Ocean region. The two isolated strains of S. aureus were found to belong to the ST152/t355 clone, a known PVL-producing S. aureus clone that circulates in Africa and is responsible for infections imported into Europe. Our two cases reinforce the hypothesis that SARS-CoV-2 infection favors the occurrence of PVL-producing S. aureus pneumonia. Production of PVL should be searched in patients returning from the Indian Ocean region who present with severe SARS-CoV-2 pneumonia complicated by superinfection with S. aureus even in the case of late onset healthcare-associated pneumonia.

2.
PLoS One ; 17(4): e0267184, 2022.
Article in English | MEDLINE | ID: covidwho-1793492

ABSTRACT

PURPOSE: No data are available on severe community-acquired pneumonia (CAP) in the French overseas department of Reunion Island. This is unfortunate as the microorganisms responsible for the disease are likely to differ from those in temperate regions due to a tropical climate and proximity to other islands of the Indian Ocean region. The aim of this study was to assess the epidemiological, clinical, prognosis, and microbiological characteristics of patients with severe CAP in Reunion Island. MATERIALS AND METHODS: This retrospective study evaluated all patients with CAP aged >18 years and hospitalized in one of the two intensive care units of Reunion Island between 2016 and 2018. Microorganisms were identified by culture from blood and respiratory samples, multiplex polymerase chain reaction from respiratory samples, urinary antigen tests, and serology. RESULTS: Over the study period, 573 cases of severe CAP were recorded, with a mean incidence of 22 per 100,000 person-years. The most frequently isolated microorganism was influenza (21.9%) followed by Streptococcus pneumoniae (12%). The influenza virus was detected in affected patients all year round. Twenty-four patients with severe CAP came from another island of the Indian Ocean region (4.2%), mainly Madagascar (>50%). Two of these patients presented with melioidosis and 4 were infected with Acinetobacter spp. CONCLUSIONS: Our findings have major implications for the management of severe CAP in tropical regions. The most frequently isolated microorganism in patients with severe CAP in Reunion Island is influenza followed by S. pneumoniae. Physicians should be aware that influenza is the main cause of severe CAP in patients living in or returning from Reunion Island, where this virus circulates all year round.


Subject(s)
Community-Acquired Infections , Influenza, Human , Pneumonia , Community-Acquired Infections/epidemiology , Humans , Pneumonia/epidemiology , Retrospective Studies , Reunion/epidemiology
3.
Antimicrob Resist Infect Control ; 10(1): 151, 2021 10 21.
Article in English | MEDLINE | ID: covidwho-1484323

ABSTRACT

Concomitant prevention of SARS-CoV-2 and extensively drug-resistant bacteria transmission is a difficult challenge in intensive care units dedicated to COVID-19 patients. We report a nosocomial cluster of four patients carrying NDM-1 plasmid-encoded carbapenemase-producing Enterobacter cloacae. Two main factors may have contributed to cross-transmission: misuse of gloves and absence of change of personal protective equipment, in the context of COVID-19-associated shortage. This work highlights the importance of maintaining infection control measures to prevent CPE cross-transmission despite the difficult context and that this type of outbreak can potentially involve several species of Enterobacterales.


Subject(s)
Carbapenem-Resistant Enterobacteriaceae/isolation & purification , Coinfection/epidemiology , Cross Infection/epidemiology , Enterobacter cloacae/isolation & purification , Enterobacteriaceae Infections/epidemiology , Infection Control/methods , Bacterial Proteins , COVID-19 , Carbapenem-Resistant Enterobacteriaceae/genetics , Disease Outbreaks , Enterobacter cloacae/genetics , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae Infections/transmission , Humans , Intensive Care Units , Personal Protective Equipment , SARS-CoV-2 , beta-Lactamases
SELECTION OF CITATIONS
SEARCH DETAIL